NCT03767790 is a NA clinical trial of iAPS in Type 1 Diabetes Mellitus, sponsored by Sansum Diabetes Research Institute.

Who is sponsoring NCT03767790?

NCT03767790 is sponsored by Sansum Diabetes Research Institute.

What drugs are being tested in NCT03767790?

Interventions in NCT03767790: iAPS.

What condition does NCT03767790 study?

NCT03767790 studies Type 1 Diabetes Mellitus.

Is NCT03767790 still recruiting?

NCT03767790 is currently completed. Last updated 8 August 2019.

Last reviewed 2019-08-08 · How we verify

NCT03767790

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting

Completed NA Last updated 8 August 2019

What this trial tests

NA trial testing iAPS in Type 1 Diabetes Mellitus in 10 participants. Completed in 27 June 2019.

Timeline

3 January 2019

Primary endpoint
27 June 2019

27 June 2019

Quick facts

Lead sponsor	Sansum Diabetes Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	3 January 2019
Primary completion	27 June 2019
Estimated completion	27 June 2019
Sites	1 location across United States

Drugs / interventions tested

iAPS

Conditions studied

Type 1 Diabetes Mellitus — all drugs for Type 1 Diabetes Mellitus →

Sponsor

Sansum Diabetes Research Institute

Who can join

18 and older, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this randomized crossover clinical trial is to 1) assess the efficacy and safety of an automated insulin delivery (AID) system using a Model Predictive Control (MPC) algorithm versus sensor augmented pump therapy (SAP)/Predictive Low Glucose Suspend (PLGS) in people with type 1 diabetes, and 2) assess the impact of different meal macronutrient content on glucose control when using AID and SAP.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Randomized Crossover Comparison of Automated Insulin Delivery Versus Conventional Therapy Using an Unlocked Smartphone with Scheduled Pasta and Rice Meal Challenges in the Outpatient Setting.
Deshpande S, Pinsker JE, Church MM, Piper M, et al · · 2020 · cited 12× · PMID 32319791 · DOI 10.1089/dia.2020.0022

Verify or expand the search:

Other trials of iAPS

Trials testing the same drug.

NCT04142229 — Artificial Pancreas With Different Stress Assessments in the Outpatient Setting · NA · completed

Other recruiting trials for Type 1 Diabetes Mellitus

Currently open trials in the same condition.

NCT07142252 — Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus · Phase 2 · recruiting
NCT07296276 — Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM · NA · recruiting
NCT07409701 — Gamification Intervertion in Children With Type 1 Diabetes · NA · recruiting
NCT07356089 — Twiist Postmarket Surveillance Study for Type 1 Diabetes · recruiting
NCT07434154 — Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults · recruiting

Other Sansum Diabetes Research Institute trials

Trials by the same sponsor.

NCT06218147 — Community-Based Nutrition-Lifestyle Therapy for Pregnant Latina Women With Diabetes · NA · completed
NCT05975242 — Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes · NA · completed
NCT05293340 — Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT") · NA · terminated
NCT04938388 — Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care · Phase 4 · terminated
NCT05000840 — Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03767790 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sansum Diabetes Research Institute
Last refreshed: 8 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03767790.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing